References
- A. Squizzato, V. E. A. Gerdes, W. Ageno & H. R. Büller. The coagulation system in endocrine disorders: A narrative review. Internal and Emergency Medicine, 2007;2,76–83.
- Massimo Franchini, Giuseppe Lippi, Franco Manzato, Pier Paolo Vescovi, Giovanni Targher. Hemostatic abnormalities in endocrine and metabolic disorders. Eur J Endocrinol. 2010;162(3):439-51.
- Stuijver, DJ, van Zaane, B, Romualdi, E. The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: a systematic review and meta-analysis. Thromb Haemost. 2012;108(6):1077–1088.
- Hulbert AJ. Thyroid hormones and their effects: a new perspective. Biol Rev Camb Philos Soc. 2000;75(4):519–631.
- Vescovi PP, Favaloro EJ, Lippi G, Garofano M, Montagnana M, Manzato F, et al. The spectrum of coagulation abnormalities in thyroid disorders. Semin Thromb Hemost. 2011;37(1):7–10.
- Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine. 2009;36(1):110–8.
- Franchini M. Hemostasis and thyroid diseases revisited. J Endocrinol Invest. 2004;27(9):886–92.
- Massimo Franchini, Pier Paolo Vescovi, Franco Manzato, Emmanuel J. Favaloro. Hormones, Endocrine Disorders, and Hemostasis. Semin Thromb Hemost 2011; 37(1): 003-006.
- Squizzato A, Romualdi E, Piantanida E et al. Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study. Thromb Haemost. 2007;97(5): 803-806.
- Stuijver DJ, Piantanida E, van Zaane B, et al. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study. Haemophilia. 2014;20(3):326–332.
- Viswanathan G, Balasubramaniam K, Hardy R, et al. Blood thrombogenicity is independently associated with serum TSH levels in post-non-ST elevation acute coronary syndrome. J Clin Endocrinol Metab. 2014;99(6): E1050–E1054.
- Kovarova M, Koller T, Stvrtinova V, et al. Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function. Endokrynol Pol. 2015;66(6):474–479.
- Angelini, D, Khorana, AA. Risk assessment scores for cancer-associated venous thromboembolic disease. Semin Thromb Hemost. 2017;43(5):469–478.
- Charalel, RA, Vedantham, S. Deep vein thrombosis interventions in cancer patients. Semin Intervent Radiol. 2017;34(1):50–53.
- Donnellan, E, Khorana, AA. Cancer and venous thromboembolic disease: a review. Oncologist. 2017;22(2):199–207.
- Streiff, MB. Thrombosis in the setting of cancer. Hematology Am Soc Hematol Educ Program. 2016;2016(1):196–205.
- Meikle CK, Kelly CA, Garg P, et al. Cancer and thrombosis: the platelet perspective. Front Cell Dev Biol. 2016;4:147.
- Marcello De Cicco. The prothrombotic state in cancer: pathogenic mechanisms. Critical Reviews in Oncology/Hematology. Volume 50, Issue 3, June 2004, Pages 187-196
- M.Y. Abou-Ismail, D. Citla Sridhar, L. Nayak. Estrogen and thrombosis: a bench to bedside review. Thromb. Res., 192 (2020), pp. 40-51.
- C. Bushnell, L.D. McCullough, I.A. Awad, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45 (5) (2014), pp. 1545-1588.
- C.D. Bushnell, S. Chaturvedi, K.R. Gage, et al. Sex differences in stroke: challenges and opportunities. J. Cereb. Blood Flow Metab., 38 (12) (2018), pp. 2179-2191.
- Stuijver DJ, Romualdi E, van Zaane B, Bax L, Büller HR, Gerdes VEA, Squizzato A. Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis. Intern Emerg Med 2015;10:219-246.
- Shahid M.Nimjee, Asad S.Akhter, Amanda Zakeri, Paco S.Herson. Sex differences in thrombosis as it affects acute ischemic stroke. Neurobiology of Disease, Volume 165, April 2022, 10564.
- North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 2012; 19:257-271.
- Curb JD, Prentice RL, Bray PF, et al. Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med 2006; 166:772-780.
- World Health Organization. Cardiovascular Disease and Steroid Hormone Contraception. Report of a WHO Scientific group. WHO Technical Report Series 877. Geneva: World Health Organization, 1998.
- Canonico M, Oger E, Plu-Bureau G, et al; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007; 115:840–845
- Lemaitre RN, Heckbert SR, Psaty BM, Smith NL, Kaplan RC, Longstreth WT Jr. Hormone replacement therapy and associated risk of stroke in postmenopausal women. Arch Intern Med 2002; 162: 1954-60
- Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002; 288: 980-7.
- Million Women Study Collaborators. Patterns of use of hormone replacement therapy in one million women in Britain, 1996–2000. BJOG 2002; 109: 1319-30.
- Brown NJ, Vaughan DE. Prothrombotic effects of angiotensin. Adv Intern Med. 2000; 45: 419-429.
- Rumbaut RE, Slaff DW, Burns AR. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation. 2005; 12: 259-274.
- Remkova A, Remko M. The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res. 2010; 59: 13-23.
- Mogielnicki A, Chabielska E, Pawlak R, Szemraj J, Buczko W. Angiotensin II enhances thrombosis development in renovascular hypertensive rats. Thromb Haemost. 2005; 93: 1069-1076.
- Stankiewicz A, Gromotowicz A, Szemraj J, Wojewódzka-Źelezniakowicz M, Skrzypkowski P, Chabielska E. Acute aldosterone infusion enhances thrombosis development in normotensive rats. Thromb Haemost 2007; 98: 697-699
- Elbers LPB, Sjouke B, Zannad F, Cicoira M, Vizzardi E, Václavík J, Gerdes VEA, Squizzato A. Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials. Thromb Res 2016; 144:32-39.
- Sechi LA, Novello M, Colussi G, Di Fabio A, Chiuch A, Nadalini E, Casanova-Borca A, Uzzau A, Catena C. Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. Am J Hypertens 2008; 21:1347–1353